GRCE Grace Therapeutics, Inc. - Common Stock
$2,19
Prix · Mai 20, 2026
Données fondamentales au Fév 12, 2026
Fourchette 52 semaines
$2–$5
12% of range
Note des analystes
BUY
8 analysts
Objectif de cours
$6
+173% upside
P/E (TTM)
-2.9
ROE
-16.1%
Marge nette
—
GRCE Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$2.19
Capitalisation Boursière
—
P/E (TTM)
-2.9
BPA (TTM)
$-0.79
Revenus (TTM)
—
Rendement div.
—
ROE
-16.1%
Dette/Capitaux propres
—
Fourchette 52 semaines
$2 – $5
GRCE Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
—
2021-03-31
→
2022-03-31
BPA
$-0.79
2022-03-31
→
2025-03-31
Flux de trésorerie libre
—
Marges
—
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
GRCE
Médiane des pairs
P/E (TTM)
-2.9
42.1
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
GRCE
Médiane des pairs
ROA
-13.2%
-48.3%
ROE
-16.1%
-85.5%
ROIC
-18.8%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
GRCE
Médiane des pairs
Current Ratio (Ratio de liquidité)
11.8
2.8
Quick Ratio (Ratio de liquidité réduite)
11.5
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
GRCE
Médiane des pairs
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
GRCE
Médiane des pairs
GRCE Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
8 analystes
- Achat fort 2 25,0%
- Achat 5 62,5%
- Conserver 1 12,5%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
2 analystes · 2026-05-14
Médiane
$5.98
← En dessous de tous les objectifs
$2.19
Bas
$3.99
Haut
$7.98
Objectif médian
$5.98
+173,2%
Objectif moyen
$5.98
+173,2%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.18%
Prochain rapport
Jui 26, 2026
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 décembre 2025 | $-0.14 | $-0.29 | 0.15% |
| 30 septembre 2025 | $-0.06 | $-0.19 | 0.13% |
| 30 juin 2025 | $-0.21 | $-0.22 | 0.01% |
| 31 mars 2025 | $0.10 | $-0.32 | 0.42% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| GRCE | — | -2.9 | — | — | -16.1% | — |
| MIRA | $63M | -1.1 | -40.3% | -10557.5% | -190.5% | — |
| TVRD | $40M | -1.3 | -66.0% | — | -67.6% | — |
| DARE | $28M | -1.6 | 10429.4% | -1300.7% | 270.9% | — |
| VERU | $56M | -5.4 | 3.6% | — | -115.4% | — |
| QCLS | — | -0.5 | — | — | — | — |
| TRAW | — | 1.4 | 1134.5% | — | — | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 15
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | · | · | · | $100M | $196.0K | |
| Cost of Revenue | · | · | · | $0 | $76.0K | |
| R&D Expense | $10M | $5M | $10M | $6M | $4M | |
| SG&A Expense | $7M | $7M | $8M | $9M | $6M | |
| Operating Income | $-17M | $-13M | $-52M | $-16M | $-16M | |
| Interest Income | $711.0K | $911.0K | $246.0K | $77.0K | $107.0K | |
| Other Non-op | $4M | $-2M | $184.0K | $5M | $-3M | |
| Pretax Income | $-13M | $-15M | $-52M | $-10M | $-20M | |
| Income Tax | $-3M | $-2M | $-10M | $-648.0K | $0 | |
| Net Income | $-10M | $-13M | $-42M | $-10M | $-20M | |
| EPS (Basic) | $-0.79 | $-1.35 | $-5.71 | $-0.27 | · | |
| EPS (Diluted) | $-0.79 | $-1.35 | $-5.71 | $-0.27 | · | |
| Shares (Basic) | 12,087,270 | 9,529,123 | 7,435,472 | 36,841,762 | · | |
| Shares (Diluted) | 12,087,270 | 9,529,123 | 7,435,472 | 36,841,762 | · | |
| EBITDA | $-17M | $-13M | $-52M | · | $-16M |
Bilan 24
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $22M | $23M | $28M | $30M | $51M | |
| Short-term Investments | · | $0 | $15.0K | $13M | $10M | |
| Receivables | · | $722.0K | $802.0K | $548.0K | $530.0K | |
| Prepaid Expense | $453.0K | $283.0K | $598.0K | $720.0K | $343.0K | |
| Current Assets | $23M | $24M | $29M | $45M | $62M | |
| PP&E (Net) | $15.0K | $24.0K | $104.0K | $21M | · | |
| PP&E (Gross) | $26.0K | $722.0K | $713.0K | · | · | |
| Accum. Depreciation | $9.0K | $608.0K | $570.0K | $446.0K | · | |
| Goodwill | $8M | $8M | $8M | $13M | · | |
| Intangibles | $41M | $41M | $41M | $70M | · | |
| Total Assets | $72M | $73M | $79M | $129M | $62M | |
| Accounts Payable | $2M | $2M | $3M | $3M | $1M | |
| Accrued Liabilities | · | $176.0K | $946.0K | $296.0K | $607.0K | |
| Current Liabilities | $2M | $2M | $3M | $3M | $2M | |
| Capital Leases | · | $0 | $410.0K | $191.0K | · | |
| Deferred Tax | $2M | $6M | $7M | $17M | · | |
| Total Liabilities | $5M | $12M | $11M | $20M | $7M | |
| Common Stock | $1.0K | $1.0K | $258M | $258M | $197M | |
| Paid-in Capital | $293M | $279M | $14M | $12M | $11M | |
| Retained Earnings | $-221M | $-211M | $-198M | $-156M | $-146M | |
| AOCI | $-6M | $-6M | $-6M | $-6M | $-6M | |
| Stockholders' Equity | $67M | $62M | $68M | $108M | $56M | |
| Liabilities + Equity | $72M | $73M | $79M | $129M | $62M | |
| Shares Outstanding | 13,718,106 | 9,399,404 | 7,435,533 | 44,288,183 | · |
Flux de trésorerie 9
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $730.0K | $913.0K | $2M | $1M | $1M | |
| Deferred Tax | $-3M | $-2M | $-10M | $-648.0K | $0 | |
| Amort. of Intangibles | · | · | · | $0 | $781.0K | |
| Operating Cash Flow | $-15M | $-12M | $-16M | $-17M | $-14M | |
| Investing Cash Flow | $0 | $104.0K | $13M | $-4M | $-10M | |
| Stock Issued | · | $0 | $304.0K | $0 | $59M | |
| Net Stock Activity | · | $0 | $304.0K | · | $59M | |
| Financing Cash Flow | $14M | $7M | $304.0K | $0 | $59M | |
| Net Change in Cash | $-872.0K | $-5M | $-2M | $-21M | $37M |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -8377.0% | |
| Net Margin | · | · | · | · | -10039.8% | |
| Pretax Margin | · | · | · | · | -10039.8% | |
| EBITDA Margin | · | · | · | · | -8377.0% | |
| ROA | -13.2% | -16.9% | -40.8% | · | -46.1% | |
| ROE | -16.1% | -20.3% | -51.5% | · | -48.4% | |
| ROIC | -18.8% | -18.2% | -62.7% | · | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 11.8 | 14.3 | 8.6 | · | 39.5 | |
| Quick Ratio | 11.5 | 14.1 | 8.4 | · | 38.8 |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.0 | |
| Receivables Turnover | · | · | · | · | 0.4 |
Taux de croissance 1
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | 50920.4% | · |
Valorisation (TTM) 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $100M | $196.0K | |
| Net Income TTM | $-10M | $-13M | $-42M | $-10M | $-20M | |
| Market Cap | · | $32M | $123M | · | · | |
| P/E | -2.9 | -2.5 | -0.5 | -27.1 | · | |
| P/B | · | 0.5 | 1.8 | · | · | |
| P / Tangible Book | · | 2.6 | 6.6 | · | · | |
| P / Cash Flow | · | -2.6 | -7.7 | · | · | |
| Earnings Yield | -34.6% | -39.4% | -206.9% | -3.7% | · |
Compte de résultat 14
| Métrique | Tendance | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $100M | |
| R&D Expense | $462.0K | $568.0K | $955.0K | $2M | $2M | $3M | $3M | $2M | $1M | $460.0K | $1M | $2M | $2M | $3M | $3M | $2M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Income | $-2M | $-3M | $-3M | $-3M | $-4M | $-5M | $-5M | $-3M | $-3M | $-2M | $-4M | $-38M | $-4M | $-5M | $-5M | $-4M | |
| Interest Income | $170.0K | $172.0K | $205.0K | $166.0K | $138.0K | $172.0K | $235.0K | $249.0K | $316.0K | $212.0K | $134.0K | $111.0K | $67.0K | $36.0K | $32.0K | $3.0K | |
| Other Non-op | $134.0K | $2M | $-272.0K | $3M | $-1M | $547.0K | $2M | $-792.0K | $444.0K | $-2M | $142.0K | $114.0K | $82.0K | $24.0K | $-36.0K | $-149.0K | |
| Pretax Income | $-2M | $-938.0K | $-3M | $-382.0K | $-5M | $-4M | $-3M | $-4M | $-3M | $-4M | $-4M | $-38M | $-4M | $-5M | $-5M | $-5M | |
| Income Tax | $0 | $0 | $0 | $-1M | $-605.0K | $-852.0K | $-724.0K | $-889.0K | $-208.0K | $-446.0K | $-289.0K | $-9M | $-274.0K | $-155.0K | $-242.0K | $-648.0K | |
| Net Income | $-2M | $-938.0K | $-3M | $636.0K | $-4M | $-3M | $-3M | $-3M | $-2M | $-3M | $-4M | $-29M | $-4M | $-5M | $-5M | $-4M | |
| EPS (Basic) | $-0.14 | $-0.06 | $-0.21 | $0.11 | $-0.36 | $-0.30 | $-0.24 | $-0.17 | $-0.21 | $-0.43 | $-0.54 | $-3.92 | $-0.52 | $-0.66 | $-0.61 | $-0.03 | |
| EPS (Diluted) | $-0.14 | $-0.06 | $-0.21 | $0.11 | $-0.36 | $-0.30 | $-0.24 | $-0.17 | $-0.21 | $-0.43 | $-0.54 | $-3.92 | $-0.52 | $-0.66 | $-0.61 | $-0.03 | |
| Shares (Basic) | 16,933,620 | 15,924,522 | 15,924,522 | -21,853,741 | 11,506,234 | 11,506,234 | 10,928,543 | -16,965,344 | 11,506,257 | 7,552,677 | 7,435,533 | -14,813,231 | 7,435,472 | 7,425,166 | 7,388,065 | -66,281,646 | |
| Shares (Diluted) | 16,933,620 | 15,924,522 | 15,924,522 | -21,853,741 | 11,506,234 | 11,506,234 | 10,928,543 | -16,965,344 | 11,506,257 | 7,552,677 | 7,435,533 | -14,813,231 | 7,435,472 | 7,425,166 | 7,388,065 | -66,281,646 | |
| EBITDA | $-2M | · | $-3M | · | · | $-5M | $-5M | · | $-3M | $-2M | $-4M | · | $-4M | $-5M | $-5M | · |
Bilan 24
| Métrique | Tendance | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $17M | $20M | $22M | $11M | $15M | $19M | $23M | $19M | $27M | $22M | $28M | $26M | $35M | $38M | $30M | |
| Short-term Investments | · | · | · | · | · | $15.0K | $15.0K | · | $7M | $15.0K | $15.0K | $15.0K | $5M | $14.0K | $16.0K | $13M | |
| Receivables | · | · | · | · | · | · | $398.0K | · | $959.0K | $837.0K | $837.0K | $802.0K | $778.0K | $859.0K | $964.0K | $548.0K | |
| Prepaid Expense | $519.0K | $416.0K | $500.0K | $453.0K | $583.0K | $477.0K | $622.0K | $283.0K | $811.0K | $1M | $1M | $598.0K | $1M | $1M | $2M | $720.0K | |
| Current Assets | $19M | $17M | $21M | $23M | $12M | $16M | $20M | $24M | $27M | $29M | $24M | $29M | $33M | $38M | $41M | $45M | |
| PP&E (Net) | · | · | · | $15.0K | · | · | · | $24.0K | · | · | · | $104.0K | · | · | · | $21M | |
| PP&E (Gross) | · | · | · | $26.0K | · | · | · | $722.0K | · | · | · | $713.0K | · | · | · | · | |
| Accum. Depreciation | · | · | · | $9.0K | · | · | · | $608.0K | · | · | · | $570.0K | · | · | · | $446.0K | |
| Goodwill | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $13M | $13M | $13M | $13M | |
| Intangibles | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $70M | $70M | $70M | $70M | |
| Total Assets | $68M | $67M | $70M | $72M | $61M | $65M | $70M | $73M | $76M | $78M | $73M | $79M | $117M | $121M | $125M | $129M | |
| Accounts Payable | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $1M | $2M | $3M | $3M | $4M | $3M | $3M | |
| Accrued Liabilities | · | · | · | · | · | · | $814.0K | · | $532.0K | $460.0K | $994.0K | $946.0K | · | · | · | $296.0K | |
| Current Liabilities | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $1M | $2M | $3M | $3M | $4M | $4M | $3M | |
| Capital Leases | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $410.0K | $430.0K | $450.0K | $174.0K | $191.0K | |
| Deferred Tax | $2M | $2M | $2M | $2M | $3M | $4M | $5M | $6M | $6M | $7M | $7M | $7M | $16M | $16M | $17M | $17M | |
| Total Liabilities | $4M | $4M | $6M | $5M | $9M | $9M | $10M | $12M | $12M | $11M | $9M | $11M | $20M | $21M | $21M | $20M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | · | · | $1.0K | · | · | $258M | · | $258M | $258M | $258M | $258M | |
| Paid-in Capital | $298M | $294M | $294M | $293M | $279M | $18M | $18M | $279M | $18M | $17M | $14M | $14M | $14M | $13M | $13M | $12M | |
| Retained Earnings | $-227M | $-225M | $-224M | $-221M | $-221M | $-217M | $-214M | $-211M | $-208M | $-206M | $-202M | $-198M | $-169M | $-165M | $-160M | $-156M | |
| AOCI | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | $-6M | |
| Stockholders' Equity | $65M | $63M | $64M | $67M | $52M | $56M | $59M | $62M | $65M | $67M | $64M | $68M | $97M | $100M | $104M | $108M | |
| Liabilities + Equity | $68M | $67M | $70M | $72M | $61M | $65M | $70M | $73M | $76M | $78M | $73M | $79M | $117M | $121M | $125M | $129M | |
| Shares Outstanding | 15,474,026 | 14,128,562 | 13,828,562 | · | 10,139,861 | · | · | · | · | · | 7,435,533 | 7,435,533 | · | · | · | 44,288,183 |
Flux de trésorerie 8
| Métrique | Tendance | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $108.0K | $206.0K | $302.0K | $130.0K | $160.0K | $202.0K | $238.0K | $229.0K | $326.0K | $280.0K | $78.0K | $322.0K | $443.0K | $582.0K | $464.0K | $616.0K | |
| Deferred Tax | $0 | $0 | $0 | $-1M | $-605.0K | $-852.0K | $-724.0K | $-891.0K | $-208.0K | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-2M | $-3M | $-2M | $-3M | $-4M | $-4M | $-4M | $-2M | $-2M | $-2M | $-6M | $-3M | $-4M | $-3M | $-5M | $-3M | |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $15.0K | $0 | $-15.0K | $7M | $-7M | $110.0K | $0 | $5M | $-5M | $-96.0K | $13M | $11.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $109.0K | $195.0K | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $195.0K | · | |
| Financing Cash Flow | $4M | $0 | $-327.0K | $14M | $0 | $0 | $0 | $0 | $0 | $7M | $0 | $0 | $0 | $109.0K | $195.0K | $0 | |
| Net Change in Cash | $2M | $-3M | $-2M | $11M | $-4M | $-4M | $-4M | $4M | $-8M | $5M | $-6M | $2M | $-9M | $-3M | $8M | $-3M |
Rentabilité 3
| Métrique | Tendance | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -3.6% | · | -4.8% | · | · | -4.8% | -3.7% | · | -2.5% | -3.3% | -4.1% | · | -3.4% | -4.1% | -4.9% | · | |
| ROE | -4.0% | · | -5.5% | · | · | -5.6% | -4.2% | · | -3.0% | -3.9% | -4.8% | · | -3.7% | -4.6% | -5.7% | · | |
| ROIC | -3.8% | · | -4.9% | · | · | -6.9% | -6.6% | · | -4.3% | -2.8% | -6.5% | · | -4.1% | -5.3% | -4.3% | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 15.0 | · | 8.9 | · | · | 6.0 | 7.9 | · | 15.2 | 20.7 | 12.0 | · | 9.7 | 9.9 | 11.1 | · | |
| Quick Ratio | 14.5 | · | 8.6 | · | · | 5.7 | 7.6 | · | 14.7 | 19.9 | 11.4 | · | 9.3 | 9.4 | 10.6 | · |
Valorisation (TTM) 7
| Métrique | Tendance | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-11M | $-12M | $-14M | · | $-13M | $-12M | $-12M | · | $-14M | $-16M | $-17M | · | $-17M | $-12M | $-10M | · | |
| Market Cap | $54M | · | $41M | · | · | · | · | · | · | · | $24M | · | · | · | · | · | |
| P/E | -4.5 | -3.2 | -2.7 | · | -3.4 | -2.5 | -2.1 | · | -1.7 | -1.3 | -1.4 | · | -1.6 | -2.5 | -6.1 | · | |
| P/B | 0.8 | · | 0.6 | · | · | · | · | · | · | · | 0.4 | · | · | · | · | · | |
| P / Tangible Book | 3.4 | 3.1 | 2.9 | · | 13.2 | · | · | · | · | · | 1.6 | · | · | · | · | · | |
| P / Cash Flow | · | · | -22.8 | · | · | · | · | · | · | · | -3.8 | · | · | · | · | · | |
| Earnings Yield | -22.2% | -31.2% | -37.4% | · | -29.7% | -39.3% | -48.6% | · | -58.8% | -77.3% | -73.3% | · | -62.7% | -39.9% | -16.5% | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | |
|---|---|---|---|---|---|
| Revenu | — | — | — | $100M | $196.0K |
| Marge d'exploitation % | — | — | — | — | -8377.0% |
| Résultat net | $-10M | $-13M | $-42M | $-10M | $-20M |
| BPA dilué | $-0.79 | $-1.35 | $-5.71 | $-0.27 | — |
Bilan
| 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 11.8 | 14.3 | 8.6 | — | 39.5 |
| Ratio de liquidité réduite | 11.5 | 14.1 | 8.4 | — | 38.8 |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.